No Serious Adverse Events After COVID-19 Vaccination in Children With History of Rare Syndrome: Study

No Serious Adverse Events After COVID-19 Vaccination in Children With History of Rare Syndrome: Study
A 7-year-old child receives a COVID-19 vaccine in Chicago on Nov. 12, 2021. Scott Olson/Getty Images
|Updated:
A study published in JAMA Network Open on Jan. 3 found that children and adolescents with a history of multisystem inflammatory syndrome (MIS-C), a rare and potentially fatal immune reaction to COVID-19 infection, reported no serious complications after receiving COVID-19 vaccinations.

“We are very reassured by the results,” said Dr. Matthew Elias, an attending cardiologist in the Cardiac Center at Children’s Hospital of Philadelphia (CHOP) and co-author of the study. “This safety data should be comforting to families and healthcare professionals when considering and recommending vaccination.”